Benefits of Achieving Robust Clot Resolution In VTE Patients Article

Aug 1, 2020 | News

The Benefits of Achieving Robust Clot Resolution In VTE Patients While Balancing Lower Risk of Adverse Events – Brian Tweddale, MD, Doylestown Hospital

The majority of VTE patients have traditionally been treated with anticoagulation alone. However, up to 50% of patients who present with lower extremity DVT develop post-thrombotic syndrome (PTS), despite being treated with anticoagulation therapy and compression therapy, while 35-50% of patients with PE who are treated with anticoagulation therapy go on to develop some form of functional limitation (Post PE syndrome).

Recent Posts

Interim Data from the RAPID-PE Study Presented at TCT 2025

Interim Data from the RAPID-PE Study Presented at TCT 2025

New Britain, PA - (October 28th, 2025) - Thrombolex, Inc. presented the prespecified interim analysis from the first 50 patients in RAPID-PE, a prospective, multicenter U.S. study evaluating On-The-Table (OTT) pharmaco-mechanical lysis (PML) without any post procedure...

read more